SNP and Gene Expression Assays as You Like It

More often than not, when a researcher needs to genotype samples for a particular single nucleotide polymorphism (SNP), or to measure the expression of a specific gene, they end up having to design the reagents for themselves. This involves identifying and validating optimal sequences, designing probes, and getting an assay system set up and running. Foster City, Calif.-based Applied Biosystems (ABI) aims to let scientists focus on their research, instead of on experimental design, with its ne

Written byHal Cohen
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

More often than not, when a researcher needs to genotype samples for a particular single nucleotide polymorphism (SNP), or to measure the expression of a specific gene, they end up having to design the reagents for themselves. This involves identifying and validating optimal sequences, designing probes, and getting an assay system set up and running. Foster City, Calif.-based Applied Biosystems (ABI) aims to let scientists focus on their research, instead of on experimental design, with its new Assays-on-Demand product line.

A simple search engine on the company's Web site gives scientists access to a genome-wide selection of over 85,000 ready-to-use assays for SNP genotyping and 7,000 for quantitative gene expression. The product line will be incrementally increased every few weeks, raising the total to 30,000 gene expression assays and 200,000 SNP genotyping assays by the end of the year. The sequences derive from both public and private human genome sequencing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies